Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
The Journal of Dermatological Treatment
|
May 1, 2019
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
Bruce E Strober, Rebecca Germino, Adriana Guana, et al.
Archives of Dermatology
|
May 17, 2006
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study
James Leyden, Diane M Thiboutot, Alan R Shalita, et al.
Journal of the American Academy of Dermatology
|
June 2, 2005
Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study
Bruce E Strober, Kimberly Siu, Andrew F Alexis, et al.
Dermatology and Therapy
|
May 11, 2025
Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes
Bruce E Strober, Michael Bukhalo, April W Armstrong, et al.
Expert Opinion on Biological Therapy
|
March 27, 2013
Pharmacovigilance and biosimilars: considerations, needs and challenges
Nicole Casadevall, I Ralph Edwards, Thomas Felix, et al.
The Journal of Dermatological Treatment
|
March 8, 2017
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab
Boni E Elewski, Lluís Puig, Margaret Mordin, et al.
Journal of Drugs in Dermatology : JDD
|
March 4, 2026
Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence
Mark G Lebwohl, James G Krueger, John Y Koo, et al.
Drug Safety
|
February 11, 2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Subrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
Journal of the American Academy of Dermatology
|
June 20, 2006
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis
Donald Belsito, David C Wilson, Erin Warshaw, et al.
The Journal of Dermatological Treatment
|
February 7, 2020
Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
Abby S Van Voorhees, Marc A Mason, Leslie R Harrold, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
The Journal of Dermatological Treatment
|
May 1, 2019
US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
Bruce E Strober, Rebecca Germino, Adriana Guana, et al.
Archives of Dermatology
|
May 17, 2006
Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel-group study
James Leyden, Diane M Thiboutot, Alan R Shalita, et al.
Journal of the American Academy of Dermatology
|
June 2, 2005
Etanercept does not effectively treat moderate to severe alopecia areata: an open-label study
Bruce E Strober, Kimberly Siu, Andrew F Alexis, et al.
Dermatology and Therapy
|
May 11, 2025
Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes
Bruce E Strober, Michael Bukhalo, April W Armstrong, et al.
Expert Opinion on Biological Therapy
|
March 27, 2013
Pharmacovigilance and biosimilars: considerations, needs and challenges
Nicole Casadevall, I Ralph Edwards, Thomas Felix, et al.
The Journal of Dermatological Treatment
|
March 8, 2017
Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab
Boni E Elewski, Lluís Puig, Margaret Mordin, et al.
Journal of Drugs in Dermatology : JDD
|
March 4, 2026
Brodalumab's 8-Year Journey in Plaque Psoriasis: Insights into Efficacy, Safety, and Real-World Evidence
Mark G Lebwohl, James G Krueger, John Y Koo, et al.
Drug Safety
|
February 11, 2019
Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn's Disease: An Integrated Analysis of Phase II/III Clinical Development Programs
Subrata Ghosh, Lianne S Gensler, Zijiang Yang, et al.
Journal of the American Academy of Dermatology
|
June 20, 2006
A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis
Donald Belsito, David C Wilson, Erin Warshaw, et al.
The Journal of Dermatological Treatment
|
February 7, 2020
Characterization of insufficient responders to ustekinumab in patients with moderate-to-severe psoriasis in the US Corrona Psoriasis Registry
Abby S Van Voorhees, Marc A Mason, Leslie R Harrold, et al.
Page
of 9